OS Therapies Inc Quarterly Operating Income (Loss) in USD from Q1 2023 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
OS Therapies Inc quarterly/annual Operating Income (Loss) history and growth rate from Q1 2023 to Q4 2024.
  • OS Therapies Inc Operating Income (Loss) for the quarter ending December 31, 2024 was -$2.97M, a 156% decline year-over-year.
  • OS Therapies Inc Operating Income (Loss) for the twelve months ending December 31, 2024 was -$6.81M, a 56.9% decline year-over-year.
  • OS Therapies Inc annual Operating Income (Loss) for 2024 was -$6.81M, a 56.9% decline from 2023.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$6.81M -$2.97M -$1.81M -156% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-31
Q3 2024 -$5M -$2.44M -$1.82M -292% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-15
Q2 2024 -$3.19M -$780K +$736K +48.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$3.92M -$630K +$418K +39.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-20
Q4 2023 -$4.34M -$1.16M Oct 1, 2023 Dec 31, 2023 10-K 2025-03-31
Q3 2023 -$622K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-15
Q2 2023 -$1.52M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$1.05M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.